BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ahmed F, Zakaria F, Enebong Nya G, Mouchli M. Sirolimus vs tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma? World J Gastrointest Surg 2022; 14(8): 862-866 [PMID: 36157369 DOI: 10.4240/wjgs.v14.i8.862]
URL: https://www.wjgnet.com/1948-9366/full/v14/i8/862.htm
Number Citing Articles
1
Mohamed E. Nady, Ola M. Abd El-Raouf, El-Sayed M. El-Sayed. Linagliptin ameliorates tacrolimus-induced renal injury: role of Nrf2/HO-1 and HIF-1α/CTGF/PAI-1Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09533-2